Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Vicente Expósito-Serrano"'
Autor:
Núria Riera-Martí, MD, Vicente Expósito-Serrano, MD, Maria Sin, MD, Marta Gamissans, MD, Cristina López-Llunell, MD, Miquel Ribera, PhD
Publikováno v:
International Journal of Women's Dermatology, Vol 9, Iss 1, p e077 (2023)
Externí odkaz:
https://doaj.org/article/9ce6ed2005224334a204e71462b2cbd2
Autor:
Gemma Melé-Ninot, Esther Serra-Baldrich, Laia Curto-Barredo, Ignasi Figueras-Nart, Jorge Spertino, Vicente Expósito-Serrano, Xavier García-Navarro, Antonio Guilabert, Isabel Bielsa-Marsol, Ana M. Giménez-Arnau
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 16, p adv00267 (2020)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/61250c0b543e43998c1f42fa5ef9c988
Publikováno v:
Actas Dermo-Sifiliográficas. 113:S23-S25
Autor:
José-Juan Pereyra-Rodríguez, Pedro Herranz, Ricardo Ruiz-Villaverde, Marta Elosua-González, Manuel Galán-Gutiérrez, Ignasi Figueras-Nart, Javier Miquel, Pablo de la Cueva, Esther Serra-Baldrich, Monica Munera-Campos, Gemma Melé-Ninot, Vicente Expósito-Serrano, Bibiana Perez, Amalia Serrano, Javier F Ortiz de Frutos, José C Armario-Hita
Publikováno v:
Clinical and Experimental Dermatology.
Background Tralokinumab was recently approved for the treatment of moderate-to-severe atopic dermatitis (AD) and is the first selective interleukin (IL)-13 inhibitor that specifically neutralizes IL-13 with high affinity. Objectives To determine the
Autor:
Vicente Expósito Serrano, Patricia Garbayo Salmons, Miquel Ribera Pibernat, Cristina López Llunell
Publikováno v:
Piel. 37:153-161
Autor:
Gemma, Melé-Ninot, Esther, Serra-Baldrich, Jorge, Spertino, Mar, Guilarte, Paula, Ribó González, Ramon, Lleonart-Bellfill, Ignasi, Figueras-Nart, Montserrat, Bonfill-Ortí, Nathalie, Depreux, Anna, Sala-Cunill, Isabel, Bielsa-Marsol, Carola, Baliu-Piqué, Verònica, Sanmartín-Novell, Xavier, Garcia-Navarro, Vicente, Expósito-Serrano, Diana, Garnica-Velandia, Maria Carmen, Diaz-Sarrió, Sara, Gómez-Armayones, Ignasi, Gich Saladich, Ana, Giménez-Arnau
Publikováno v:
European journal of dermatology : EJD. 32(5)
The guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend adding omalizumab to the treatment of patients with uncontrolled disease despite four-fold doses of second-generation antihistamines (AH). On the contrary, some studies
Autor:
Jorge Romaní de Gabriel, Miquel Ribera Pibernat, Vicente Expósito Serrano, Patricia Garbayo Salmons
Publikováno v:
Piel. 35:494-499
Autor:
Cristina López Llunell, Patricia Garbayo Salmons, Miquel Casals Andreu, Vicente Expósito Serrano, Miquel Ribera Pibernat
Publikováno v:
Piel. 35:361-363
Autor:
Patricia Garbayo-Salmons, Mireia Moreno Martínez-Losa, Vicente Exposito-Serrano, Miquel Ribera, Joan Calvet
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/de7fd9ca276846949cce1e1e26cea4e5
Autor:
E Serra-Baldrich, Xavier García-Navarro, Antonio Guilabert, Gemma Melé-Ninot, Vicente Expósito-Serrano, Ignasi Figueras-Nart, J. Spertino, Isabel Bielsa-Marsol, Laia Curto-Barredo, Ana Giménez-Arnau
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 16, p adv00267 (2020)
is missing (Short communication)